Literature DB >> 11077070

Influence of thyroid hormone on 5-HT(1A) and 5-HT(2A) receptor-mediated regulation of hippocampal BDNF mRNA expression.

V A Vaidya1, M E Castro, Q Pei, M E Sprakes, D G Grahame-Smith.   

Abstract

The aim of the present study was to determine the influence of thyroid hormone, T3, on the regulation of hippocampal BDNF expression by 5-HT receptor agonists. Chronic T3 administration prior to treatment with the 5-HT(1A) agonist, 8-OH-DPAT, significantly decreased BDNF mRNA in the dentate gyrus region of the hippocampus. Administration of 8-OH-DPAT did not alter hippocampal BDNF mRNA expression in naive, euthyroid rats. Pretreatment with the 5-HT(1A) antagonist, WAY 100635, completely blocked the 8-OH-DPAT-induced down-regulation of BDNF mRNA in chronic T3-treated rats. Acute T3 administration prior to 8-OH-DPAT treatment led to a small, but significant, decrease in hippocampal dentate gyrus BDNF mRNA. Acute or chronic administration of T3 did not alter the decrease in hippocampal BDNF mRNA induced by the 5-HT(2A/2C) receptor agonist, DOI. The influence of 8-OH-DPAT and DOI on hippocampal BDNF mRNA was also unaltered in rats rendered hypothyroid by propylthiouracil administration. Chronic T3 treatment or hypothyroidism did not influence the basal expression of hippocampal BDNF mRNA. The affinity and density of 5-HT(1A) receptors, and the hippocampal expression of 5-HT(1A) mRNA were also not influenced by chronic T3 treatment. The results of this study clearly demonstrate a powerful interaction between thyroid hormone and the 5-HT(1A) receptor in the regulation of hippocampal BDNF expression. Crosstalk between signal transduction cascades influenced by T3 and 5-HT(1A) receptors may mediate the synergistic effects of these systems on hippocampal BDNF expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11077070     DOI: 10.1016/s0028-3908(00)00094-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Is the thyroid still important in major depression?

Authors:  Russell T Joffe
Journal:  J Psychiatry Neurosci       Date:  2006-11       Impact factor: 6.186

2.  Novel two-dimensional morphometric maps and quantitative analysis reveal marked growth and structural recovery of the rat hippocampal regions from early hypothyroid retardation.

Authors:  Arash Farahvar; Esmail Meisami
Journal:  Exp Neurol       Date:  2007-01-29       Impact factor: 5.330

Review 3.  Brain-Derived Neurotrophic Factor-Mediated Cognitive Impairment in Hypothyroidism.

Authors:  U Madhusudhan; Kalpana M; Vidya Singaravelu; Vidya Ganji; Nitin John; Archana Gaur
Journal:  Cureus       Date:  2022-04-01

Review 4.  The role of serotonin neurotransmission in rapid antidepressant actions.

Authors:  A L Pehrson; D Roberts; A Khawaja; R McNair
Journal:  Psychopharmacology (Berl)       Date:  2022-03-25       Impact factor: 4.530

Review 5.  Subclinical thyroid dysfunction and major depressive disorder.

Authors:  Grigorios N Karakatsoulis; Eva-Maria Tsapakis; Calypso Mitkani; Konstantinos N Fountoulakis
Journal:  Hormones (Athens)       Date:  2021-08-24       Impact factor: 2.885

6.  Chronic exposure to a predator or its scent does not inhibit male-male competition in male mice lacking brain serotonin.

Authors:  Ying Huo; Qi Fang; Yao-Long Shi; Yao-Hua Zhang; Jian-Xu Zhang
Journal:  Front Behav Neurosci       Date:  2014-04-08       Impact factor: 3.558

7.  Hippocampal gene expression of deiodinases 2 and 3 and effects of 3,5-diiodo-L-thyronine T2 in mouse depression paradigms.

Authors:  Natalyia Markova; Anton Chernopiatko; Careen A Schroeter; Dmitry Malin; Aslan Kubatiev; Sergey Bachurin; João Costa-Nunes; Harry M W Steinbusch; Tatyana Strekalova
Journal:  Biomed Res Int       Date:  2013-12-10       Impact factor: 3.411

8.  Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region.

Authors:  Tahmineh Mokhtari; Mohammad Akbari; Fatemeh Malek; Iraj Ragerdi Kashani; Tayebeh Rastegar; Farshid Noorbakhsh; Mahmoud Ghazi-Khansari; Fatemeh Attari; Gholamreza Hassanzadeh
Journal:  Daru       Date:  2017-02-15       Impact factor: 3.117

9.  Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

Authors:  L Urigüen; I Gil-Pisa; E Munarriz-Cuezva; E Berrocoso; J Pascau; M L Soto-Montenegro; A Gutiérrez-Adán; B Pintado; J L M Madrigal; E Castro; P Sánchez-Blázquez; J E Ortega; M J Guerrero; M Ferrer-Alcon; J A García-Sevilla; J A Micó; M Desco; J C Leza; A Pazos; J Garzón; J J Meana
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

10.  Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Authors:  Rita Kočárová; Jiří Horáček; Robin Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-07-19       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.